UBS Group’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-4,800
Closed -$160K 7907
2018
Q4
$160K Buy
4,800
+4,200
+700% +$145K ﹤0.01% 5128
2018
Q3
$23K Buy
+600
New +$21.3K ﹤0.01% 6725

Other funds holding IHI

UBS Group's IHI Position: Q1 2026 in Review

UBS Group reduced its iShares US Medical Devices ETF (IHI) stake by 7.4% in Q1 2026, selling an estimated $4.45M and leaving 946,706 shares worth $50.5M. The position accounts for 0.01% of the portfolio, ranked #1626.

UBS Group first reported a position in IHI in Q4 2014 and has held it in 46 quarters since. The position peaked at $124M in Q4 2020. 504 funds tracked by Wall St. Rank hold IHI as of Q1 2026.

  • UBS Group held 946,706 shares of iShares US Medical Devices ETF worth $50.5M as of Q1 2026.
  • UBS Group sold 75,836 iShares US Medical Devices ETF shares in Q1 2026, an estimated $4.45M.
  • iShares US Medical Devices ETF made up 0.01% of UBS Group's portfolio in Q1 2026, its #1626 holding.
  • UBS Group first reported a position in iShares US Medical Devices ETF in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's iShares US Medical Devices ETF position peaked at $124M in Q4 2020.
  • 504 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.